Evidence map›Paper›PMID 24748592›Full record

ArticleAmerican journal of physiology. Heart and circulatory physiology2014

Reduction of Na/K-ATPase affects cardiac remodeling and increases c-kit cell abundance in partial nephrectomized mice.

Christopher A Drummond, Moustafa Sayed, Kaleigh L Evans, Huilin Shi, Xiaoliang Wang, Steven T Haller, Jiang Liu, Christopher J Cooper, Zijian Xie, Joseph I Shapiro and 1 more

Abstract read
In one paragraph

Article in American journal of physiology. Heart and circulatory physiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. [Research progress on the pathogenesis and clinical treatment of cirrhotic cardiomyopathy].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2026
    Review
  2. Review
  3. Article
  4. Review
  5. The Redox-Sensitive Na/K-ATPase Signaling in Uremic Cardiomyopathy.International journal of molecular sciences · 2020
    Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Christopher A DrummondDepartment of Medicine, University of Toledo, Toledo, Ohio;
Moustafa SayedDepartment of Medicine, University of Toledo, Toledo, Ohio;
Kaleigh L EvansDepartment of Medicine, University of Toledo, Toledo, Ohio;
Huilin ShiDepartment of Medicine, University of Toledo, Toledo, Ohio;
Xiaoliang WangDepartment of Physiology Pharmacology, University of Toledo, Toledo, Ohio; and.
Steven T HallerDepartment of Medicine, University of Toledo, Toledo, Ohio;
Jiang LiuJoan C. Edwards School of Medicine, Marshall University, Huntington, West Virginia.
Christopher J CooperDepartment of Medicine, University of Toledo, Toledo, Ohio;
Zijian XieDepartment of Physiology Pharmacology, University of Toledo, Toledo, Ohio; and.
Joseph I ShapiroJoan C. Edwards School of Medicine, Marshall University, Huntington, West Virginia.
Jiang TianDepartment of Medicine, University of Toledo, Toledo, Ohio; jiang.tian@utoledo.edu.

Funding

Receptor Na/K-ATPase Antagonists As Novel Therapeutics For Renal/Cardiac DiseasesR01HL109015 · NHLBI · UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS · PI SHAPIRO, JOSEPH ISAAC, XIE, ZIJIAN · 2011 to 2014
$2.2M
Na/K-ATPase Reduction in Renal Disease-Related Cardiac DysfunctionR01HL105649 · NHLBI · UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS · PI TIAN, JIANG · 2012 to 2016
$1.8M
NHLBI NIH HHS R01 HL105649NHLBI NIH HHS R01-HL-105649NHLBI NIH HHS R01 HL109015NHLBI NIH HHS R01-HL-109015
6 · The paper itself

Abstract

The current study examined the role of Na/K-ATPase α1-subunit in animals subjected to 5/6th partial nephrectomy (PNx) using Na/K-ATPase α1-heterozygous (α1(+/-)) mice and their wild-type (WT) littermates. After PNx, both WT and α1(+/-) animals displayed diastolic dimension increases, increased blood pressure, and increased cardiac hypertrophy. However, in the α1(+/-) animals we detected significant increases in cardiac cell death in PNx animals. Given that reduction of α1 elicited increased cardiac cell death with PNx, while at the same time these animals developed cardiac hypertrophy, an examination of cardiac cell number, and proliferative capabilities of those cells was carried out. Cardiac tissues were probed for the progenitor cell marker c-kit and the proliferation marker ki-67. The results revealed that α1(+/-) mice had significantly higher numbers of c-kit-positive and ki-67-positive cells, especially in the PNx group. We also found that α1(+/-) mice express higher levels of stem cell factor, a c-kit ligand, in their heart tissue and had higher circulating levels of stem cell factor than WT animals. In addition, PNx induced significant enlargement of cardiac myocytes in WT mice but has much less effect in α1(+/-) mice. However, the total cell number determined by nuclear counting is higher in α1(+/-) mice with PNx compared with WT mice. We conclude that PNx induces hypertrophic growth and high blood pressure regardless of Na/K-ATPase content change. However, total cardiac cell number as well as c-kit-positive cell number is increased in α1(+/-) mice with PNx.

Indexed as

Cell ProliferationNephrectomyAnimalsApoptosisAtrial RemodelingCardiomegalyDisease Models, AnimalHypertensionMaleMiceMice, KnockoutMyocytes, CardiacProto-Oncogene Proteins c-aktProto-Oncogene Proteins c-kitSodium-Potassium-Exchanging ATPaseTOR Serine-Threonine KinasesmTOR protein, mouseProto-Oncogene Proteins c-aktProto-Oncogene Proteins c-kitSodium-Potassium-Exchanging ATPaseTOR Serine-Threonine KinasesapoptosisATPasescardiac hypertrophycardiac progenitor cellscardiotonic steroidscaspasecell proliferationstem cellsuremic cardiomyopathy

Identifiers

PMID24748592
PMCPMC4059984

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.